U.S. Transportation Stock News

In recent days, Strategy Inc., the Bitcoin-focused former MicroStrategy, saw its vast holding of 840,447 BTC swing back to an unrealized profit of about US$1.40 billion as Bitcoin rebounded above its average acquisition price, helped by supportive comments from President Donald Trump and bond-market interventions by the U.S. Treasury. The episode underscores how closely Strategy’s investment story is tied to policy signals and Bitcoin’s price, with capital decisions such as pausing new BTC...

Halliburton stock has delivered an 89.1% return over the past 5 years, and the latest valuation checks still suggest the shares screen as inexpensive on several fronts. This raises the question of how much of the story is already reflected in the current price. Over 5 years, Halliburton has returned 89.1%, which points to meaningful value creation for longer term holders. Halliburton’s push into higher tech oilfield services and new applications like nuclear waste drilling can support...

Marathon Petroleum recently highlighted that global gasoline and diesel supplies remain tight as refinery outages strain already low inventories, prompting the company to concentrate output on the strongest demand segments while expanding refining capabilities and exporting record levels of distillates to Latin America and Europe. An interesting angle is that refined fuel prices have risen faster than crude oil in 2026, creating especially supportive conditions for refiners such as Marathon...

Amentum Holdings has recently secured the US$974 million Center Maintenance, Operations, and Engineering II contract at NASA’s Langley Research Center, where it will provide engineering support, maintenance, and modernization of critical research facilities including wind tunnels and laboratories. This win, alongside fresh nuclear and defense work in the UK and Australia, deepens Amentum’s role in complex, long-duration government programs that can enhance its revenue visibility and...

Rising U.S. Treasury yields are quietly reshaping the trade off between stocks and bonds, as higher “safe” income tempts cash off the sidelines and puts equity valuations under the microscope. For investors who care about portfolio income, this shift can feel like both a threat and a potential upgrade. This article walks through 3 stocks from our income focused screener that appear closely tied to this rate story. The three stocks highlighted below are just a starting sample, since the full...

Fresh interest in CBRE Group (CBRE) has been sparked by its latest Scoring Tech Talent report, which now ranks New York City ahead of the San Francisco Bay Area as the largest U.S. tech talent hub. See our latest analysis for CBRE Group. These fresh data points on tech and industrial demand arrive as CBRE Group trades at US$152.10, with a 30 day share price return of 10.95% but a year to date share price decline of 5.05%. The 3 year total shareholder return of 84.19% contrasts with a 1 year...

Microsoft stock has delivered a 68.0% gain over the past 5 years, yet current checks suggest it now trades close to what a Discounted Cash Flow (DCF) estimate would call its intrinsic value, while earnings-based multiples still screen it as undervalued. This mix leaves investors weighing a solid long-term share price record against signals that the valuation is no longer clearly cheap. Over 5 years, Microsoft has returned 68.0%, which shows long-term shareholders have already captured a...

PulteGroup recently reported past second-quarter 2026 results that exceeded earnings and total revenue expectations, even as home sale revenues and deliveries declined year over year. A 6.4% increase in net new home orders and a 1.7% rise in the backlog to 10,966 homes suggest underlying demand remains firm despite broader housing-market pressures. We’ll now examine how resilient net new orders and a growing backlog may reshape PulteGroup’s existing investment narrative and risk...

Ultra Clean Holdings, Inc. previously filed a US$400 million at-the-market follow-on equity offering of common stock, adding flexibility to raise capital over time. This sizeable potential issuance raises questions about how additional equity funding might interact with the company’s existing efficiency, integration, and diversification initiatives. We’ll now examine how the planned US$400 million at-the-market equity program could alter Ultra Clean’s investment narrative and risk-reward...

In August 2026, Harmonic Inc. reported past second-quarter results showing revenue rising to US$133.46 million while swinging from a prior-year profit to a net loss, and confirmed it had completed the sale of its Video business to focus on broadband operations. At the same time, Harmonic raised its full-year 2026 broadband revenue and earnings guidance, highlighting confidence in its pure-play broadband model backed by a larger backlog and demand for fiber and its broader broadband...

Earlier this month, Veralto reported strong Q2 FY2026 results, with sales growth led by its Water Quality segment and a 19.4% increase in adjusted EPS, and management raised full-year 2026 adjusted diluted EPS guidance to reflect its expectations for stronger performance. This combination of robust segment performance and higher earnings guidance highlights how Veralto’s water-focused portfolio is currently translating into improving profitability and management confidence. Next, we’ll...

Mondelez International (MDLZ) has put fresh attention on its stock after raising its 2026 organic net revenue growth outlook and announcing its first professional football sponsorship with the Kansas City Chiefs. See our latest analysis for Mondelez International. The Kansas City Chiefs sponsorship and raised 2026 organic net revenue outlook have coincided with building momentum in Mondelez International’s shares, with a 20.13% year to date share price return compared with a more modest 5.17%...

Pediatrix Medical Group stock reacts to concerns over demand Recent commentary on Pediatrix Medical Group (MD) has focused on declining revenue and limited sales growth momentum. This has raised fresh questions about demand for its specialized neonatal and pediatric healthcare services. See our latest analysis for Pediatrix Medical Group. The recent revenue concerns sit against a share price that has climbed 24.8% year to date and 24.98% over 90 days. The 1-year total shareholder return of...

Earlier this week, Freddie Mac reported in its Primary Mortgage Market Survey that the average 30-year fixed-rate mortgage fell to 6.65%, with Chief Economist Sam Khater highlighting that borrowers can save thousands by comparing lenders. This shift in borrowing costs directly ties into Freddie Mac’s role in supporting housing affordability and could influence mortgage demand and funding activity. With mortgage rates easing slightly and Freddie Mac emphasizing potential borrower savings,...

Cooling inflation is already reshaping expectations for Social Security cost of living adjustments, and that ripple effect could matter a lot for companies tied to senior housing and care. A projected 2027 COLA in the 3.4% to 3.6% range still points to meaningful income support for millions of retirees, which keeps this corner of the market firmly on the radar. This article walks through three stocks from our senior focused screener that appear particularly exposed to this COLA driven...

Albertsons Companies, Inc. recently reported first-quarter 2026 adjusted earnings that fell short of consensus expectations and cut its full-year earnings outlook, prompting multiple law firms to investigate potential securities-related misconduct by the company and certain executives. At the same time, shareholders voted against a proposal for a detailed human rights report while the company approved amendments to its restated certificate of incorporation, highlighting governance and...

WhiteFiber, Inc. has completed a US$270 million Rule 144A convertible senior unsecured notes offering with a 5% coupon, due September 1, 2032, following its earlier announcement of a 2032 convertible note issuance and its second-quarter 2026 results showing revenue of US$28.84 million and a net loss of US$14.98 million. On August 12, 2026, WhiteFiber, Inc. announced an agreement making it Krambu, Inc.’s exclusive GPU infrastructure operator for 100MW of planned high-density data center...

The RealReal (REAL) recently drew attention after Zacks upgraded the stock to a Rank #2, following an upward trend in earnings estimates that points to improving confidence in the company’s underlying resale marketplace model. See our latest analysis for RealReal. Despite the recent Zacks upgrade, RealReal’s share price has been under some pressure in the very short term, with a 1 day share price return of 4.55% lower and a 7 day share price return of 2.46% lower. That sits against a 90 day...

NVIDIA stock has delivered a very large 5 year gain, yet today the valuation checks present more of a mixed picture as our Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares are roughly in line with fair value while the market multiple screen still tilts supportive. Over 5 years, NVIDIA has returned about 8.5x an initial investment, which means many holders are now weighing how much further upside is justified by current fundamentals. The build out of AI infrastructure...

Avnet, Inc. recently announced that its Board of Directors approved a 5.7% increase in the quarterly cash dividend to US$0.37 per share, payable on September 23, 2026 to shareholders of record as of September 9, 2026, and also completed a US$548.85 million fixed-income offering of 5.650% senior unsecured notes due September 1, 2031. This combination of a higher cash payout and fresh long-term funding highlights how Avnet is balancing near-term shareholder income with financing flexibility...

Recent coverage of Option Care Health (OPCH) has focused on its valuation metrics, which compare favorably with industry averages, along with references to an earnings outlook that has drawn fresh attention from value oriented investors. See our latest analysis for Option Care Health. At a latest share price of US$23.70, Option Care Health has recorded a 30 day share price return of 12.06% and a 90 day share price return of 13.23%, although the year to date share price return is down 26.49%...

Earlier this week, Biogen raised its non-GAAP EPS guidance, pointing to expected launch growth and five upcoming Phase 3 trial readouts in lupus, transplant, and rare diseases. This guidance shift underscores how management is leaning on emerging therapies to counterbalance pressure in legacy franchises and reshape Biogen’s earnings mix. We’ll now explore how Biogen’s upgraded earnings guidance and reliance on late-stage trial outcomes could influence the company’s existing investment...

With Washington now applying 50% tariffs on US$20b of Canadian imports and Ottawa preparing dollar-for-dollar retaliation, the long talked about shift toward onshoring suddenly feels more real. This disruption to steel, autos, lumber, and other cross border flows could reshape where factories sit and where capital goes. This article walks through 3 stocks exposed to this news and why they may matter for your watchlist. The three stocks below are just a starting sample, since the full screen...

Why Mineralys Therapeutics Stock Is In Focus After Earnings And Leadership Change Mineralys Therapeutics (MLYS) is on investors’ radar after second quarter 2026 results showed a net loss of US$241.07 million, alongside the appointment of James J. Ferguson III, M.D., as Chief Medical Officer. See our latest analysis for Mineralys Therapeutics. Mineralys Therapeutics’ recent news arrives after a mixed run for investors, with the share price down 5.04% over 30 days and 14.07% over 90 days, yet a...